{{Rsnum
|rsid=4568789
|Chromosome=1
|position=184345277
|Orientation=plus
|GMAF=0.4123
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 8.2 | 40.0 | 51.8
| HCB | 12.4 | 37.2 | 50.4
| JPT | 13.5 | 42.3 | 44.1
| YRI | 56.2 | 37.0 | 6.8
| ASW | 50.0 | 39.3 | 10.7
| CHB | 12.4 | 37.2 | 50.4
| CHD | 12.8 | 41.3 | 45.9
| GIH | 7.1 | 57.1 | 35.7
| LWK | 50.5 | 44.0 | 5.5
| MEX | 14.3 | 50.0 | 35.7
| MKK | 41.3 | 40.6 | 18.1
| TSI | 9.1 | 42.4 | 48.5
| HapMapRevision=28
}}

{{PMID|17876339}} [[rs4568789]] (chromosome 1q25) and tagSNP [[rs13225697]] (chromosome 7p21) to be significantly associated with prostate cancer (P-values 0.009 and 0.008, respectively).

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}